These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 19181929

  • 21. Serum levels of sFas and sFasL during chemotherapy of lung cancer.
    Naumnik W, Izycki T, Ossolinska M, Chyczewska E.
    Exp Oncol; 2007 Jun; 29(2):132-6. PubMed ID: 17704746
    [Abstract] [Full Text] [Related]

  • 22. Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.
    Nakae H, Narita K, Endo S.
    J Crit Care; 2001 Jun; 16(2):59-63. PubMed ID: 11481600
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis.
    Cipriani P, Fulminis A, Pingiotti E, Marrelli A, Liakouli V, Perricone R, Pignone A, Matucci-Cerinic M, Giacomelli R.
    J Rheumatol; 2006 Oct; 33(10):2003-14. PubMed ID: 17014016
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Fas and Fas ligand: Expression and soluble circulating levels in bile duct carcinoma.
    Murakami M, Sasaki T, Miyata H, Yamasaki S, Kuwahara K, Chayama K.
    Oncol Rep; 2004 Jun; 11(6):1183-6. PubMed ID: 15138553
    [Abstract] [Full Text] [Related]

  • 30. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
    Seki M, Ushiyama C, Seta N, Abe K, Fukazawa T, Asakawa J, Takasaki Y, Hashimoto H.
    Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733
    [Abstract] [Full Text] [Related]

  • 31. Soluble form of TRAIL, Fas and FasL in the serum of patients with B-CLL.
    Jabłońska E, Kiersnowska-Rogowska B, Rogowski F, Parfieńczyk A, Puzewska W, Bukin M.
    Rocz Akad Med Bialymst; 2005 May; 50():204-7. PubMed ID: 16358967
    [Abstract] [Full Text] [Related]

  • 32. Circulating soluble Fas concentration in breast cancer patients.
    Ueno T, Toi M, Tominaga T.
    Clin Cancer Res; 1999 Nov; 5(11):3529-33. PubMed ID: 10589768
    [Abstract] [Full Text] [Related]

  • 33. Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus.
    Song le H, Binh VQ, Duy DN, Bock TC, Kremsner PG, Luty AJ, Mavoungou E.
    J Med Virol; 2004 Jun; 73(2):244-9. PubMed ID: 15122799
    [Abstract] [Full Text] [Related]

  • 34. Increased apoptosis of peripheral blood lymphocytes and its association with interleukin-18 in patients with active untreated adult-onset Still's disease.
    Chen DY, Hsieh TY, Hsieh CW, Lin FJ, Lan JL.
    Arthritis Rheum; 2007 Dec 15; 57(8):1530-8. PubMed ID: 18050226
    [Abstract] [Full Text] [Related]

  • 35. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Su DL, Wang HJ, Ji XH, Li YY, Xuan HB, Heng C, Li YF.
    Acta Pharmacol Sin; 2006 Aug 15; 27(8):1051-7. PubMed ID: 16867258
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Soluble Fas receptor and soluble Fas ligand in the serum of women with uterine tumors.
    Kondera-Anasz Z, Mielczarek-Palacz A, Sikora J.
    Apoptosis; 2005 Oct 15; 10(5):1143-9. PubMed ID: 16151647
    [Abstract] [Full Text] [Related]

  • 38. The alteration of Fas receptor and ligand system in hepatocellular carcinomas: how do hepatoma cells escape from the host immune surveillance in vivo?
    Nagao M, Nakajima Y, Hisanaga M, Kayagaki N, Kanehiro H, Aomatsu Y, Ko S, Yagita H, Yamada T, Okumura K, Nakano H.
    Hepatology; 1999 Aug 15; 30(2):413-21. PubMed ID: 10421649
    [Abstract] [Full Text] [Related]

  • 39. Serum soluble Fas levels in patients with autoimmune rheumatic diseases.
    Sahin M, Aydintug O, Tunc SE, Tutkak H, Naziroğlu M.
    Clin Biochem; 2007 Jan 15; 40(1-2):6-10. PubMed ID: 17056024
    [Abstract] [Full Text] [Related]

  • 40. Measurement of soluble Fas antigen and ligand in circulating serum and intra-abdominal or cerebrospinal fluid during gastrointestinal or cerebrovascular surgery.
    Iwama H, Kato M, Ohmori S, Akimaru K, Tsutsumi K, Tohma J, Nakamura N.
    J Crit Care; 2000 Sep 15; 15(3):119-25. PubMed ID: 11011825
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.